The Spine Movement – May 2012

Choll Kim, MD, PhD gives a breakdown of some of the most exciting presentations in MIS at ISASS12, and looks ahead to ISASS13 in Vancouver.

Minimally Invasive Surgery Was Huge at ISASS12

ISASS12 in Barcelona was a remarkable venue for numerous presentations related to minimally invasive spine surgery. Great interest both in the US and abroad continues to grow in this area of spine surgery: MIS made up the content for one-third of all the general sessions, with a sprinkling of individual presentations in other general sessions.

The range and complexity of the MIS topics proved broad. One of the most striking findings emerging in the literature is the marked decrease in infections when minimally invasive surgery is performed. Pfandistiener et al. from the Clinic for Spine Surgery with Scoliosis Center in Germany reported on infection rates between open and MIS posterior instrumentation. In 284 open surgeries, deep infections were seen in 2.46%. In contrast, 199 patients underwent percutaneous posterior instrumentation procedures without a single infection.

The use of minimally invasive strategies to treat ever more complex conditions were highlighted. Phillips and co-workers presented the prospective, multi-center results of 107 adult degenerative scoliosis with 24 month follow-up. Excellent clinical results and a low complications were encountered in this this challenging group of patients with advanced age and co-morbidities. Anand showed similar results in 33 patients from a single site.

The fusion rates of minimally invasive interbody fusion remains high. As shown in a meta-analysis by Gwinn et al. from Walter Reed Medical Center, the MIS TLIF technique enjoys a greater than 95% fusion rate.

Topics in endoscopic surgery continue to generate interest, as well–Nagahama et al. (Hokkaido University) and Schubert (Munich, Germany) showed continued success of this promising procedure in the hands of experienced endoscopic spinal surgeons.

Lingering questions regarding MIS were also addressed: Lee et al. (University of California, San Diego) quantitatively examined hip flexion strength after the popular transpsoas lateral lumbar interbody fusion (XLIF/DLIF/LLIF). As experienced by many surgeons, hip flexion strength decreased in most patients immediately postoperation, but returned to baseline within 2 weeks of surgery.

Cost effectiveness of open versus MIS TLIF was assessed by Phillips et al. on worker’s compensation patients; the cost of overall inpatient care was slightly less for MIS than for open.

Pimenta et al. advised appropriate caution when he described low fusion success rates of 2-level AxiaLIF procedures. In their review of 27 patients undergoing L4-S1 2-level AxiaLIF, only 22% of patients were considered to have solid fusion at 2 year follow-up.

Emerging MIS technologies were presented by a wide variety of groups. Regev et al. from Tel Aviv Sourasky Medical Center described the minimally invasive transforaminal, thoracic microscopic discectomy; Husain et al. from Loma Linda University described a percutaneous cervical transfacet fixation technique; Araghi et al. showed the results of the first 40 Guyer Lumbar Interbody Fusion (GLIF) procedures; MacMillan described a novel all transosseous approach to the L5-S1 disc, and both Julien (West Virginia University) and Sharma et al. (Manassas, VA) described the use of percutaneous stabilization for thoracolumbar fractures. It is heartening to see so many attempts to make the best of minimally invasive technology in this still pioneering area of spine surgery.

Santos et al. (University of Minnesota) showed that 3-D navigation may be used to improve safety and accuracy of percutaneous pedicle screw placement. Finally, the potential changes in healthcare delivery were highlighted by Smith and Christian (Las Vegas, NV) when they showed that selected MIS fusions may be performed in the ambulatory setting.

The diversity of topics was matched only by the excitement surrounding them. I’m looking forward to even more fascinating research by my colleagues at ISASS13 in Vancouver.

Choll Kim, MD, PhD
Spine Institute of San Diego

joimax® at the early summer congresses: SpineWeek Amsterdam and DGNC Leipzig

Karlsruhe, May 28th 2012. After the very successful Britspine at the beginning of May in Newcastle in the UK the slogan is now “joimax® goes oranje“ – up, up and away to the SpineWeek in Amsterdam (May 28th to June 1st 2012). This conference is held by the leading international scientific societies in the field of spinal diseases. Up to 3000 participants from all over the world are expected and it is hence the biggest conference of this kind in Europe.

Under the motto “Sharing today’s ideas, shaping tomorrow’s practice” joimax® invites all its distribution partners to a meeting. Central topic will be joimax®’s new products and a special focus will be laid on the Deflector Blades for Shrill® – the Shaver-Drill-System which is indispensible in stenosis treatment. During this meeting Dr. Menno Iprenburg, long standing joimax® faculty member, will hold a presentation on his own success story. In spring 2010 he had opened his “Ruegkliniek” in Veenhuizen in the Netherlands with an exclusive specialization on endoscopic spine surgery with the joimax® systems. Right from the start the clinic was very popular. After a consumer program on Dutch TV, where the advantages of the surgery method and very satisfied patients were presented, the staff of Dr. Iprenburg virtually can’t handle the huge demand for appointments for surgery. A really striking success story in medicine!

“joimax® goes Leipzig” – at the 63rd annual conference of the DGNC (German Society for Neurosurgery) in Leipzig, Germany (June 13th to 16th, 2012), joimax® will focus on the newest technologies in pain therapy with the Multiuse Set for endoscopic facet joint denervation. Dr. Bernd Illerhaus from Recklinghausen, Germany will talk about his experience with this system during the joimax® Lunch Symposium on June 14th, 2012. Assoc. Prof. Dr. Sandro Eustacchio from the University Clinic for Neurosurgery in Graz, Austria will report on the application of TESSYS® and iLESSYS® – the transforaminal and interlaminar access systems of joimax® for the treatment of lumbar herniated discs and spinal canal stenosis.

Of special interest is the fact that the Japanese sister society to the DGNC joins in the meeting this year. Hence, there will be ample opportunity to make important contacts and set further mile stones for the upcoming entry of the Japanese market. In the meantime – thanks to very active partners – business in China and South Korea is steadily increasing – “joimax® goes Asia”.